Maternal Substance Use During Pregnancy and Congenital Syphilis Among Hospitalized Neonates

OBJECTIVES: US congenital syphilis (CS) cases have increased 10-fold in the past decade, exceeding 3700 cases in 2022. This study evaluated the association between maternal substance use during pregnancy and CS among hospitalized neonates by region and year. METHODS: codes and categorized maternal substance use as no substance use, single substance use, or polysubstance use. Using survey-weighted multivariable logistic regression, we tested effect modification by region and year. RESULTS: Among 4 531 346 hospitalized neonates, 217 220 (weighted prevalence = 2.5%) had maternal substance use during pregnancy. CS prevalence among substance-exposed neonates increased 467% from 2.5 to 14.5 per 1000 neonates between 2016 and 2022, compared with 0.2 to 0.8 per 1000 neonates among unexposed neonates. After adjusting for demographic charateristics, health insurance status, median household income, housing insecurity, year, and region, single substance use and polysubstance use were associated with higher odds of CS (single substance use: adjusted odds ratio [AOR] = 9.68; 95% CI, 8.88-10.55; and polysubstance use: AOR = 17.18; 95% CI, 15.21-19.40). We observed a significant effect modification: the association was much stronger in the West region of the United States (interaction OR = 4.80; 95% CI, 3.10-7.44) than in the Northeast, and the polysubstance use association was significantly elevated in 2022 relative to 2016 (interaction OR = 3.10; 95% CI, 1.81-5.30). CONCLUSIONS: Maternal substance use was strongly associated with CS. These findings underscore the need to address structural barriers to prenatal care through the expansion and integration of syphilis screening within substance use treatment and harm-reduction contexts, especially in regions with a high burden of CS.

Authors

Institutions

Publication Details

Journal
Public Health Reports
Published
2026-11-20
DOI
https://doi.org/10.1177/00333549261497292
Primary Topic
Syphilis Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Maternal Substance Use During Pregnancy and Congenital Syphilis Among Hospitalized Neonates

Su Jin Joo, Sarah Leir, Hebatalla Shamseldin, Amy Koid
Public Health Reports
Syphilis Diagnosis and Treatment
article

Maternal Substance Use During Pregnancy and Congenital Syphilis Among Hospitalized Neonates

Su Jin Joo, Sarah Leir, Hebatalla Shamseldin, Amy Koid
article en

Abstract

OBJECTIVES: US congenital syphilis (CS) cases have increased 10-fold in the past decade, exceeding 3700 cases in 2022. This study evaluated the association between maternal substance use during pregnancy and CS among hospitalized neonates by region and year. METHODS: codes and categorized maternal substance use as no substance use, single substance use, or polysubstance use. Using survey-weighted multivariable logistic regression, we tested effect modification by region and year. RESULTS: Among 4 531 346 hospitalized neonates, 217 220 (weighted prevalence = 2.5%) had maternal substance use during pregnancy. CS prevalence among substance-exposed neonates increased 467% from 2.5 to 14.5 per 1000 neonates between 2016 and 2022, compared with 0.2 to 0.8 per 1000 neonates among unexposed neonates. After adjusting for demographic charateristics, health insurance status, median household income, housing insecurity, year, and region, single substance use and polysubstance use were associated with higher odds of CS (single substance use: adjusted odds ratio [AOR] = 9.68; 95% CI, 8.88-10.55; and polysubstance use: AOR = 17.18; 95% CI, 15.21-19.40). We observed a significant effect modification: the association was much stronger in the West region of the United States (interaction OR = 4.80; 95% CI, 3.10-7.44) than in the Northeast, and the polysubstance use association was significantly elevated in 2022 relative to 2016 (interaction OR = 3.10; 95% CI, 1.81-5.30). CONCLUSIONS: Maternal substance use was strongly associated with CS. These findings underscore the need to address structural barriers to prenatal care through the expansion and integration of syphilis screening within substance use treatment and harm-reduction contexts, especially in regions with a high burden of CS.

Public Health Reports
Harvard University (US), University of Ottawa (CA), University of California, San Francisco (US), University of California System (US), Mount St. Mary's University (US), Global Brain Health Institute (US), Mount St. Mary's University (US)
Syphilis Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon